글로벌 3세대 시퀀싱 시장 – 2030년까지의 산업 동향 및 예측

3세대 시퀀싱 시장 분석 및 규모

세상이 더욱 디지털화됨에 따라 3세대 시퀀싱 시장의 합법성도 함께 증가합니다. 기술적 진보와 생물의학 연구는 한때 변두리 관행으로 여겨졌지만 이제는 하이테크 기업과 과학자들로 북적입니다. 3세대 시퀀싱 애플리케이션이 매우 다양하기 때문에 최근 몇 년 동안 이 서비스 시장이 폭발적으로 성장한 것은 놀라운 일이 아닙니다. 이러한 확장은 주로 조기 질병 탐지 및 개인화된 의학에 대한 수요 증가로 인해 이루어질 것으로 예상됩니다.

Data Bridge Market Research는 2022년에 90억 1,000만 달러였던 3세대 시퀀싱 시장이 2030년까지 287억 3,000만 달러에 도달할 것으로 분석했으며, 2023년부터 2030년까지의 예측 기간 동안 연평균 성장률은 15.60%에 이를 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

3세대 시퀀싱 시장 범위 및 세분화  

Market Definition

The third-generation sequencing (TGS) era of DNA sequencing technology has gained a place in biology as a way to study genomes, transcriptomes, and metagenomes at unprecedented resolution. These technologies use single-molecule sequencing to provide the following benefits: long reads with no amplification, direct detection of epigenetic modifications on native DNA, and direct sequencing through regions of the genome that are inaccessible or difficult to analyze using short-read platforms.

Global Third Generation Sequencing Market Dynamics

Drivers

• Rising applications of Third-generation sequencing

Third-generation sequencing technologies can produce much longer reads than second-generation sequencing technologies. These advantages have significant implications for genomic science as well as general biology research. These technologies are actively being developed, and reductions in high error rates are expected. These all are the certain factors that help the market to grow.

Opportunities

• Technological advances

Certain factors driving market growth include advances in sequencing technology, increased application in clinical diagnosis and drug discovery, and increased R&D investments. DNA sequencing can be used for diagnostics, personalized medicine, biomarkers, forensics, reproductive health, and other purposes. Third generation sequencing technology has enormous potential in cancer diagnostics and therapeutics clinical research and development. Next-generation sequencing (NGS) technology has recently demonstrated its capability as a high-throughput and cost-effective approach to identifying and characterising clinically actionable genetic variants across multiple genes in a single test.

Restraints/Challenges

• Risk associated with sequencing

The easy availability of substitutes, combined with unfavourable government policies and the risk associated with sequencing, are likely to hamper the growth of the third generation sequencing market during the forecast period. The biggest challenge to market growth will be the economy's recession, combined with rising competition among competitors.

This third generation sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the third generation sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Third Generation Sequencing Market Scope

The third generation sequencing market is segmented on the basis of type, application,. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Single Molecule Real Time (SMRT) DNA Sequencing
• Nanopore-based Single-Molecule Analysis Technology
• Other

Application

• Genome Sequencing
• Methylation Studies
• Single Nucleotide Polymorphisms (SNP) Detection

Third Generation Sequencing Market Regional Analysis/Insights

The third generation sequencing market is analyzed and market size insights and trends are provided by country, type, application, as referenced above.

The countries covered in the third generation sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the third generation sequencing market because of the high prevalence of breast cancer patients.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the focus of various established market players to expand their presence in this particular region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The third generation sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for third generation sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the third generation sequencing market. The data is available for historic period 2011-2021.

Competitive Landscape and Third Generation Sequencing Market Share Analysis

3세대 시퀀싱 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 3세대 시퀀싱 시장과 관련된 회사의 초점에만 관련이 있습니다.

3세대 시퀀싱 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Thermo Fisher Scientific, Inc. (미국)
• 일루미나 주식회사(미국)
• QIAGEN(독일)
• F. 호프만-라 로슈 유한회사(스위스)
• Oxford Nanopore Technologies Ltd. (영국)
• 마크로젠 주식회사(한국)
• 퍼킨 엘머 주식회사(미국)
• 캘리포니아 태평양 바이오사이언스 주식회사(미국)
• BGI(중국)
• Bio-Rad Laboratories, Inc. (미국)
• Myriad Genetics (미국)
• Agilent Technologies, Inc. (미국)

SKU-52520